
The European Commission has formally opened an antitrust probe into a 2018 deal between tech giants Google and Facebook allegedly aimed at cementing their dominance over the online advertising market, reported Bloomberg.
The EU’s executive said it was investigating the so-called “Jedi Blue” agreement to see if it had been used to “restrict and distort competition in the already concentrated ad tech market.”
The European Commission announced its formal antitrust investigation in a press release in which it voiced its concerns that an agreement between the two companies in 2018 may have breached EU competition rules.
Meanwhile, the UK’s Competition and Markets Authority (CMA) said that the deal may have restricted or prevented the uptake of header bidding services.
The Jedi Blue agreement came under fire in the United States in September 2021, after four members of Congress asked the Justice Department to launch a criminal investigation into whether the pact violated federal antitrust laws.
Header bidding is a service that allows sellers like news publishers to offer their online advertising space to multiple buyers at the same time as opposed to doing so on an individual basis. This makes it so that buyers (or in this case advertisers) must compete against each other for ad space while publishers can compare bids from multiple buyers at the same time.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas